Literature DB >> 9003143

Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race.

M Monane1, R L Bohn, J H Gurwitz, R J Glynn, R Levin, J Avorn.   

Abstract

OBJECTIVES: This study measured compliance and related demographic factors in a retrospective cohort of 4068 elderly outpatients newly starting antihypertensive therapy from 1982 through 1988.
METHODS: Logistic regression modeling of data from the New Jersey Medicaid program was used.
RESULTS: These patients filled antihypertensive prescriptions covering an average of only 179 days in the 365-day follow-up period (49%) Good compliance (> or = 80%) was associated with advanced age (odds ratio [OR] = 2.12, for patients 85 or older) and White race (OR = 0.55 for Blacks). There was no relationship between compliance and gender.
CONCLUSIONS: Despite the efficacy of antihypertensive therapy in preventing cardiovascular morbidity, such high rates of noncompliance may contribute to suboptimal patient outcomes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9003143      PMCID: PMC1380739          DOI: 10.2105/ajph.86.12.1805

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  35 in total

1.  The implications of blood pressure variability for clinical and screening purposes.

Authors:  B Rosner; B F Polk
Journal:  J Chronic Dis       Date:  1979

2.  Hypertension--a community problem.

Authors:  J A Wilber; J G Barrow
Journal:  Am J Med       Date:  1972-05       Impact factor: 4.965

3.  The dropout problem in antihypertensive treatment. A pilot study of social and emotional factors influencing a patient's ability to follow antihypertensive treatment.

Authors:  J R Caldwell; S Cobb; M D Dowling; D de Jongh
Journal:  J Chronic Dis       Date:  1970-02

4.  Trends in medication choices for hypertension in the elderly. The decline of the thiazides.

Authors:  M Monane; R J Glynn; J H Gurwitz; R L Bohn; R Levin; J Avorn
Journal:  Hypertension       Date:  1995-05       Impact factor: 10.190

5.  Drug treatment of hypertension in the elderly: a meta-analysis.

Authors:  J T Insua; H S Sacks; T S Lau; J Lau; D Reitman; D Pagano; T C Chalmers
Journal:  Ann Intern Med       Date:  1994-09-01       Impact factor: 25.391

6.  The determinants of hypertension awareness, treatment, and control in an insured population.

Authors:  D H Stockwell; S Madhavan; H Cohen; G Gibson; M H Alderman
Journal:  Am J Public Health       Date:  1994-11       Impact factor: 9.308

7.  The costs of interrupting antihypertensive drug therapy in a Medicaid population.

Authors:  J S McCombs; M B Nichol; C M Newman; D A Sclar
Journal:  Med Care       Date:  1994-03       Impact factor: 2.983

8.  Process versus outcome in hypertension: a positive result.

Authors:  R B Haynes; E S Gibson; D W Taylor; C D Bernholz; D L Sackett
Journal:  Circulation       Date:  1982-01       Impact factor: 29.690

9.  Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy.

Authors:  J H Gurwitz; J Avorn; R L Bohn; R J Glynn; M Monane; H Mogun
Journal:  JAMA       Date:  1994-09-14       Impact factor: 56.272

10.  Noncompliance with congestive heart failure therapy in the elderly.

Authors:  M Monane; R L Bohn; J H Gurwitz; R J Glynn; J Avorn
Journal:  Arch Intern Med       Date:  1994-02-28
View more
  73 in total

Review 1.  The association of depression with adherence to antihypertensive medications: a systematic review.

Authors:  Chete M Eze-Nliam; Brett D Thombs; Bruno B Lima; Cheri G Smith; Roy C Ziegelstein
Journal:  J Hypertens       Date:  2010-09       Impact factor: 4.844

Review 2.  Effect of partial compliance on cardiovascular medication effectiveness.

Authors:  Joyce A Cramer
Journal:  Heart       Date:  2002-08       Impact factor: 5.994

3.  Racial differences in adherence to cardiac medications.

Authors:  Hyasmine Charles; Chester B Good; Barbara H Hanusa; Chung-Chou H Chang; Jeff Whittle
Journal:  J Natl Med Assoc       Date:  2003-01       Impact factor: 1.798

4.  Obesity Modifies the Association of Race/Ethnicity with Medication Adherence in the CARDIA Study.

Authors:  Maribel Salas; Catarina I Kiefe; Pamela J Schreiner; Yongin Kim; Lucia Juarez; Sharina D Person; O Dale Williams
Journal:  Patient       Date:  2008-01-01       Impact factor: 3.883

5.  Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study.

Authors:  Walid F Gellad; Jennifer S Haas; Dana Gelb Safran
Journal:  J Gen Intern Med       Date:  2007-09-20       Impact factor: 5.128

6.  The Iowa Continuity of Care study: Background and methods.

Authors:  Barry L Carter; Karen B Farris; Paul W Abramowitz; David B Weetman; Peter J Kaboli; Jeffrey D Dawson; Paul A James; Alan J Christensen; John M Brooks
Journal:  Am J Health Syst Pharm       Date:  2008-09-01       Impact factor: 2.637

Review 7.  Assessing medication adherence in the elderly: which tools to use in clinical practice?

Authors:  Eric J MacLaughlin; Cynthia L Raehl; Angela K Treadway; Teresa L Sterling; Dennis P Zoller; Chester A Bond
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

8.  Use of hormonal therapy in senior breast cancer patients treated with or without radiotherapy.

Authors:  S P Krotneva; A Ramjaun; K E Reidel; T Eguale; N Trabulsi; N Mayo; R Tamblyn; A N Meguerditchian
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

9.  Racial differences in blood pressure control: potential explanatory factors.

Authors:  Hayden B Bosworth; Benjamin Powers; Janet M Grubber; Carolyn T Thorpe; Maren K Olsen; Melinda Orr; Eugene Z Oddone
Journal:  J Gen Intern Med       Date:  2008-02-21       Impact factor: 5.128

10.  Defining an evidence-based cutpoint for medication adherence in heart failure.

Authors:  Jia-Rong Wu; Debra K Moser; Marla J De Jong; Mary Kay Rayens; Misook L Chung; Barbara Riegel; Terry A Lennie
Journal:  Am Heart J       Date:  2008-12-24       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.